Innodata Inc. announced that a Fortune 500 insurance company has expanded its scope of services with Innodata to support its medical record predictive model development. The expansion adds approximately $700,000 of anticipated one-time revenue to the revenue estimates previously announced on September 15, 2021 of approximately $3 million of one-time revenue and $800,000 per year of ongoing annual revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.62 USD | -8.04% |
|
+20.26% | +146.44% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.44% | 61Cr | |
-7.14% | 20TCr | |
+10.15% | 18TCr | |
+14.16% | 17TCr | |
+6.98% | 10TCr | |
+39.34% | 8.98TCr | |
+12.28% | 8.56TCr | |
+11.87% | 8.55TCr | |
+7.06% | 5.08TCr | |
-32.34% | 4.56TCr |
- Stock Market
- Equities
- INOD Stock
- News Innodata Inc.
- Innodata Expands Scope with Fortune 500 Client